Rafael Sobrano Fais

41 posts

Rafael Sobrano Fais

Rafael Sobrano Fais

@FaisSobrano

Indianapolis, IN Katılım Mart 2021
101 Takip Edilen29 Takipçiler
Rafael Sobrano Fais
Rafael Sobrano Fais@FaisSobrano·
Here’s another piece of the puzzle showing how endothelin‑1–induced NLRP3 activation links to IL‑1β signaling, which inhibits SK3 channels, thereby driving endothelial dysfunction, vascular inflammation, and erectile dysfunction. mdpi.com/2218-273X/16/3…
English
0
0
0
15
Rafael Sobrano Fais retweetledi
Kurt Prins
Kurt Prins@kurt_prins·
nature.com/articles/s4146…. Sample size of 30 for RNAseq now? Let’s hope they increase NIH funding 10-fold. Wonder what we need to do for single cell sequencing?
English
0
1
3
160
Rafael Sobrano Fais retweetledi
Colin E Evans 🫀🫁
Colin E Evans 🫀🫁@EvansLaboratory·
Jingbo Dai (Zhao lab), Madelyn Blake (@kurt_prins lab), Yonan Shi (Chan lab), and Rafael Fais (Lahm lab) are competing for the Cournand & Comroe Early Career Award #AHA24 Also attending, previous Zhao lab members: @joeydai and yours truly @EvansLaboratory
Colin E Evans 🫀🫁 tweet media
English
1
3
3
381
Rafael Sobrano Fais retweetledi
Kurt Prins
Kurt Prins@kurt_prins·
Outstanding work from our @3CPRCouncil rising stars!
Kurt Prins tweet media
English
0
5
17
739
Rafael Sobrano Fais retweetledi
Vinicio de Jesus Perez, MD FAHA FCCP ATSF
I am excited to announce that the de Jesus Perez lab at Stanford University has an open postdoc position! Join a highly collaborative and supportive team on lung endothelial-pericyte biology and PAH. Candidates can send their CV and cover letter to vdejesus@stanford.edu
English
0
17
41
2.7K
Rafael Sobrano Fais retweetledi
Roham Zamanian
Roham Zamanian@docroham·
A pleasure to help pave to define disease modification in PAH. An honor to work with a superb group of colleagues - Exciting think-tank style collab, along with the ever-so-important patient perspective pubmed.ncbi.nlm.nih.gov/38471030/ @PHatStanford @AlbertaPHdoc @PVRI
Vinicio de Jesus Perez, MD FAHA FCCP ATSF@Viniciodjperez

Are we ready for “disease modification”? We got the scoop! Check out the paper-available today online.

English
0
5
13
1.4K
Rafael Sobrano Fais retweetledi
Vinicio de Jesus Perez, MD FAHA FCCP ATSF
The Wall Center at Stanford was privileged to host four experts in pulmonary vascular medicine from LATAM. The Wall Center-LATAM initiative aims to create a partnership to promote PH education, research, and patient advocacy. This is part of our commitment to PH global health.
Vinicio de Jesus Perez, MD FAHA FCCP ATSF tweet media
English
0
10
29
1.2K
Rafael Sobrano Fais retweetledi
simoncomerma
simoncomerma@simoncomerma·
Rodent animal data correlated so well to positive phase 2A proof of concept of IP2018 in young patients with depression and erectile dysfunction linkedin.com/posts/simon-co…
English
1
5
11
1.7K
Rafael Sobrano Fais retweetledi
Tim Lahm
Tim Lahm@TimLahm·
Txs for the opportunity to contribute a review and educate the community! @ATS_PC @3CPRCouncil @PVRI @PHAssociation @NJHealthMedEd @DenPulm @CU_PSCCM
BMJMedicine@BMJMedicine

#PulmonaryHypertension is a progressive and often fatal condition. This #review describes key features of #pulmonaryarterialhypertension, discusses therapeutic interventions, & points future directions for research and patient care ▶️ bit.ly/3ZqoP9X #MedTwitter @LabLahm

English
0
11
25
1.6K
Rafael Sobrano Fais retweetledi
Tim Lahm
Tim Lahm@TimLahm·
Fantastic talk by the twitterless Dr. Brad Maron on endothelial-platelet interactions in #CTEPH. And who knew he has personal ties to @NJHealth? Thanks so much for the visit! @NJHealthMedEd @CU_PSCCM @DenPulm
Tim Lahm tweet media
English
1
3
17
1.8K
Rafael Sobrano Fais retweetledi